Jon is a Principal in the Medicxi investment team with main focus on early-stage opportunities. Prior to Medicxi, Jon worked at Index as an Associate for two years. Before that, he worked as a life science strategy consultant at ClearView Healthcare Partners. He is on the boards of Palladio Biosciences, Z-Factor UltraHuman Ltd and Impact Biomedicines. He is also an observer on the board of Capella Bioscience and Apcintex.
Jon obtained his PhD in biochemistry and biophysics from UNC Chapel Hill and also conducted postdoctoral research at MIT, where he is an affiliate in the department of biological engineering.